![Joern-Peter Halle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joern-Peter Halle
Corporate Officer/Principal bij
MERCK KGAA
Profiel
Dr. Joern-Peter Halle is a Venture Partner at Biogeneration Management BV and a Chief Strategy Officer at Merck KGaA.
Dr. Halle also served on the board at iOnctura SA.
He received his doctorate degree from Universität Konstanz.
Actieve functies van Joern-Peter Halle
| Bedrijven | Functie | Begin |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | 01-01-2022 |
Biogeneration Management BV
 Biogeneration Management BV Investment ManagersFinance Biogeneration Management invests in companies located in the United States, Netherlands and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for pre-seed, seed and early stage capital requirements. It also acts as lead investor. | Private Equity Investor | 01-04-2024 |
Eerdere bekende functies van Joern-Peter Halle
| Bedrijven | Functie | Einde |
|---|---|---|
iOnctura SA
 iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Directeur/Bestuurslid | - |
Opleiding van Joern-Peter Halle
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
33
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Universität Konstanz
 Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management invests in companies located in the United States, Netherlands and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for pre-seed, seed and early stage capital requirements. It also acts as lead investor. | Finance |
iOnctura SA
iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Health Technology |
